Showing results (2261-2270 of 7,557) with videos related to

Sort By:
Pageof 756
Molecular Pharmaceutics|April 7, 2012
Oral gene delivery with cyclo-(D-Trp-Tyr) peptide nanotubesWei-Hsien Hsieh, Shwu-Fen Chang, Hui-Min Chen, et al.
Molecular Pharmaceutics|February 7, 2013
Vascular physiology and protein disposition in a preclinical model of neurodegenerationC Andrew Boswell, Eduardo E Mundo, Bernadette Johnstone, et al.
Molecular Pharmaceutics|February 27, 2013
In vitro to in vivo extrapolation and physiologically based modeling of cytochrome P450 mediated metabolism in beagle dog gut wall and liverAki T Heikkinen, Stephen Fowler, Lynn Gray, et al.
Molecular Pharmaceutics|February 28, 2013
Functional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and humanDongli Sun, Yuqing Wang, Fuqing Tan, et al.
Molecular Pharmaceutics|March 9, 2013
Physicochemical and biological characterization of synthetic phosphatidylinositol dimannosides and analoguesMadlen Hubert, Benjamin J Compton, Colin M Hayman, et al.
Molecular Pharmaceutics|March 12, 2013
Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites modelFerenc Zsila
Molecular Pharmaceutics|March 12, 2013
Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classificationSophia Y K Fong, Mary Liu, Hai Wei, et al.
Molecular Pharmaceutics|March 14, 2013
Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturationYan Yan Yeap, Natalie L Trevaskis, Tim Quach, et al.
Molecular Pharmaceutics|February 14, 2013
Physicochemical and DMPK in silico models: facilitating their use by medicinal chemistsDaniel F Ortwine, Ignacio Aliagas
Molecular Pharmaceutics|February 14, 2013
Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cellsYingjie Wei, Baojian Wu, Wen Jiang, et al.
Pageof 756